EUVIMEDEUVIMED entdecken
Fallbericht

Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations

Hui-Dan Li, Si-Si Chen, Jing Ding, Chun-Ling Zhang, Hui-Yin Qiu, Xin-Xin Xia, Jun Yang, Xiao-Rui Wang

Annals of Hematology · 2024

DOI: 10.1007/s00277-024-05917-3 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Annals of Hematology, 2024. Verfasst von Hui-Dan Li und 7 weiteren Autor:innen. Beteiligte Einrichtung: Clinical Laboratory Medicine Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200080, China. Hauptthemen laut MEDLINE: fms-Like Tyrosine Kinase 3, Nucleophosmin, Leukemia, Myeloid, Acute, Proto-Oncogene Proteins c-ets. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Clinical Research Innovation Plan of Shanghai General Hospital, Shanghai Hospital Development Center.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

fms-Like Tyrosine Kinase 3NucleophosminLeukemia, Myeloid, AcuteProto-Oncogene Proteins c-etsNuclear ProteinsETS Translocation Variant 6 ProteinMutationOncogene Proteins, FusionRepressor ProteinsHumansMaleProto-Oncogene Proteins c-ablAdultSorafenibAntineoplastic Combined Chemotherapy ProtocolsDasatinibFemaleHematopoietic Stem Cell Transplantation

Stichwörter der Autor:innen

AMLAllo-HSCTDual TKIs therapyETV6:ABL1FLT3-ITDNPM1

Substanzen

NPM1 protein, humanfms-Like Tyrosine Kinase 3NucleophosminProto-Oncogene Proteins c-etsFLT3 protein, humanNuclear ProteinsETS Translocation Variant 6 ProteinOncogene Proteins, FusionRepressor ProteinsProto-Oncogene Proteins c-abl

Autor:innen und Institutionen

  • Clinical Laboratory Medicine Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200080, China.
  • Clinical Research Center, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
  • Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China.
  • Department of Hematology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, 200080, China. yangjuan74@sina.com.
  • Clinical Laboratory Medicine Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, 200080, China. Xiaorui.wang@shgh.cn.

Förderung

  • National Natural Science Foundation of China
  • Clinical Research Innovation Plan of Shanghai General Hospital
  • Shanghai Hospital Development Center

Zitieren

APA

Li, H. D., Chen, S. S., Ding, J., Zhang, C. L., Qiu, H. Y., Xia, X. X., Yang, J., & Wang, X. R. (2024). Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations. Annals of Hematology. https://doi.org/10.1007/s00277-024-05917-3

Vancouver

Li HD, Chen SS, Ding J, Zhang CL, Qiu HY, Xia XX, et al. Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations. Annals of Hematology. 2024. doi:10.1007/s00277-024-05917-3

BibTeX
@article{Li2024,
  author = {Li, Hui-Dan and Chen, Si-Si and Ding, Jing and Zhang, Chun-Ling and Qiu, Hui-Yin and Xia, Xin-Xin and Yang, Jun and Wang, Xiao-Rui},
  title = {Exploration of ETV6::ABL1-positive AML with concurrent NPM1 and FLT3-ITD mutations},
  journal = {Annals of Hematology},
  year = {2024},
  doi = {10.1007/s00277-024-05917-3}
}
Kostenlos starten →